Senova Technology Co.
Senova Technology Co., Ltd. is a Shenzhen-headquartered, FDA-inspected Chinese pharmaceutical supplier founded in 2013 that produces APIs, peptides, advanced intermediates, fine chemicals, and CDMO services for global pharmaceutical manufacturers and generic drug developers across 60+ countries.
- Company typePrivate
- Founded2013
- HeadquartersShenzhen, China
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Senova Technology Co. does
Senova Technology Co., Ltd. is a privately held Chinese pharmaceutical supplier founded in 2013 and headquartered in Shenzhen, with an R&D center in Hangzhou and an FDA-approved GMP manufacturing facility in Chenggu, Shanxi Province. The company produces and sells Active Pharmaceutical Ingredients (APIs), pharmaceutical peptides, advanced intermediates, and fine chemicals, with particular depth in SGLT2 inhibitors (Dapagliflozin, Empagliflozin, Canagliflozin), peptide products such as Tirzepatide, JAK inhibitors, and pharmaceutical-grade amino acids. Production capacity spans pilot-scale (10-100L) through commercial-scale (1000-5000L) reactors, with documented monthly API output in the hundreds to low thousands of kilograms for its lead molecules.
The company monetizes primarily through one-time sales of APIs, peptides, and intermediates under quote-based B2B pricing, supplemented by professional services revenue from CMO/CDMO engagements and regulatory documentation support (DMF/CMC/SMF preparation, pre-audit, audit, and document translation). Senova holds 20+ invention patents, 15+ quality and regulatory certificates including FDA EIR, EU-GMP, CEP, ISO 9001:2015, and Chinese GMP, and exports to 60+ countries serving 1,300+ customers globally.
Go-to-market is event-driven, with primary customer acquisition through participation in CPHI Worldwide, CPHI regional events (China, Japan, Korea), API China, and Asia Pharma Expo, complemented by direct export sales follow-up. The company targets two principal customer segments — pharmaceutical manufacturers producing commercial drugs and generic drug developers from R&D through commercialization — both requiring GMP-certified ingredients with full regulatory documentation. Recent operating moves include a December 2024 headquarters relocation to expanded office space and a 2025 CPHI Frankfurt debut signaling elevated European market intent.
Senova Technology Co. firmographics
Firmographics- Name
- Senova Technology Co.
- Legal name
- SENOVA TECHNOLOGY CO., LTD
- Website
- https://senovatech.com
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Senova Technology Co., Ltd. is a Shenzhen-headquartered, FDA-inspected Chinese pharmaceutical supplier founded in 2013 that produces APIs, peptides, advanced intermediates, fine chemicals, and CDMO services for global pharmaceutical manufacturers and generic drug developers across 60+ countries.
- Ownership category
- akta.pro rank
Senova Technology Co. industry classification
Industry- Product category
- Active Pharmaceutical Ingredients (APIs)
- NAICS
- Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM)
- akta.pro secondary industries
- Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA) (HLAGAKAA), Impurity / Reference Standard Synthesis & Characterization (HLAGAHAG)
Keywords
Where Senova Technology Co. is headquartered
LocationHeadquarters
- HQ city
- Shenzhen
- HQ country
- China
- HQ region
- Asia
Offices3 records
Markets served
Senova Technology Co. business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- API Sales: Sale of Active Pharmaceutical Ingredients including Anti-Viral, Anti-Infection, Anti-Bacteria, Anti-Coagulants, Anti-Cancer products, and Anti-Diabetes medications (SGLT2 inhibitors like Dapagliflozin, Empagliflozin, Canagliflozin). Products supplied with GMP quality and full documentation support.
- Peptide Sales: Sale of pharmaceutical peptides including Tirzepatide and amino acid series. Products include both pharmaceutical grade and food/feed grade amino acids.
- Advanced Intermediates Sales: Sale of key intermediates and advanced intermediates for pharmaceutical synthesis, including intermediates for various therapeutic areas.
- CDMO/CMO Services: Contract manufacturing and development services including process development, tech transfer, and manufacturing support for APIs and intermediates at various scales.
- Regulatory Services: DMF/CMC/SMF preparation services, pre-audit support, and document translation services for regulatory compliance in global markets.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom pricing based on product type, quantity, and regulatory requirements |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Senova Technology Co. product offering
Product offeringCore offering
Senova Technology Co., Ltd. manufactures and sells Active Pharmaceutical Ingredients (APIs), peptides, advanced intermediates, and fine chemicals from FDA- and EU-GMP-approved facilities. The company supplies anti-viral, anti-bacterial, anti-cancer, anti-coagulant, and anti-diabetes APIs (including SGLT2 inhibitors and Tirzepatide peptide) to global pharmaceutical manufacturers, and offers CMO/CDMO services along with DMF/CMC/SMF regulatory documentation, pre-audit, and translation support.
Product overview
Senova Technology Co., Ltd. is a pharmaceutical supplier company offering a comprehensive portfolio of products and services. The core offerings include Active Pharmaceutical Ingredients (APIs) across multiple therapeutic categories (Anti-Viral, Anti-Infection, Anti-Bacteria, Anti-Coagulants, Anti-Cancer, Anti-Diabetes), Advanced Intermediates for pharmaceutical synthesis, Peptides including Tirzepatide, and Fine Chemicals. The company also provides CMO/CDMO manufacturing services, regulatory document preparation (DMF/CMC/SMF), pre-audit and audit services, and document translation services. The product portfolio centers on GLP-1 related products as their core business line, supplemented by SGLT2 inhibitors (Empagliflozin, Dapagliflozin, Canagliflozin), JAK Inhibitors, and Pharmaceutical Grade Amino Acids.
Differentiator
Problem solved
Functional benefit
Products and services
- Active Pharmaceutical Ingredients (APIs) Manufactured APIs across therapeutic categories including anti-viral, anti-infection, anti-bacteria, anti-coagulants, anti-cancer, and anti-diabetes, supplied with GMP quality and full documentation for pharmaceutical manufacturers.
- Anti-Diabetes APIs (SGLT2 Inhibitors) SGLT2 inhibitor APIs including Dapagliflozin, Empagliflozin, and Canagliflozin for treatment of type 2 diabetes, with monthly production capacities ranging from 500 to 1500 kg from GMP-certified facilities.
- Anti-Viral APIs Active pharmaceutical ingredients used in antiviral medications, supplied to global pharmaceutical manufacturers with regulatory documentation.
- Anti-Bacteria APIs Active pharmaceutical ingredients used in antibacterial medications, supplied with GMP quality.
- Anti-Coagulants APIs Active pharmaceutical ingredients used in anticoagulant medications, supplied with regulatory documentation.
- Anti-Cancer APIs Active pharmaceutical ingredients used in anticancer medications, manufactured to GMP standards.
- JAK Inhibitors Series Medications that target Janus kinase enzymes for treatment of inflammatory and autoimmune diseases.
- Tirzepatide (Peptide) Novel dual GIP and GLP-1 receptor agonist peptide for type 2 diabetes, providing improved glycemic control and weight reduction.
- Advanced Intermediates Synthesizes basic compounds and key intermediates for pharmaceutical production, supporting API manufacturing processes.
- Pharmaceutical Grade Amino Acids High-purity amino acids for pharmaceutical applications, including β-Nicotinamide adenine dinucleotide, N-Acetyl-L-leucine, L-Hydroxyproline, and others; also offers food/feed grade amino acids.
- Fine Chemicals High-quality specialty chemicals for various industrial applications.
- CMO/CDMO Services Comprehensive Contract Manufacturing (CMO) and Contract Development (CDMO) services offering tailored solutions for pharmaceutical development and manufacturing, including process development, improvement, tech transfer, and manufacturing at pilot (10-100L) to commercial scale (1000-5000L reactors).
- Regulatory Documentation Services (DMF/CMC/SMF) Preparation of Drug Master Files (DMF), Chemistry Manufacturing and Controls (CMC), and Site Master Files (SMF) for regulatory compliance across global markets, including pre-audit/audit support and document translation services.
Quantifiable outcome
- Supplying products to 1300+ customers in 60+ countries
- +1 more outcomes
Companies that use Senova Technology Co.
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles2 records
Senova Technology Co. technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Senova Technology Co. partnerships and signals
Strategic signalScale indicators9 records
Recent moves7 records
Expansion highlights5 records
Senova Technology Co. competitors and assessment
Company assessmentBroad incumbents
- WuXi AppTec: China's largest CRO/CDMO with end-to-end drug development and commercial manufacturing. While substantially larger and broader than Senova, it competes for similar CDMO mandates and shares the Chinese-origin regulatory scrutiny.
- Dr. Reddy's Laboratories: India-based global API and generic manufacturer with FDA-inspected facilities, competing directly with Senova in SGLT2 and other generic APIs. A larger incumbent peer in the same competitive set.
- Aurobindo Pharma: Among the world's largest API manufacturers by volume, headquartered in India, with extensive FDA approvals and a broad therapeutic API portfolio including diabetes and anti-infectives. A scale leader peer.
Direct peers
- Zhejiang Hisun Pharmaceutical: One of China's largest API manufacturers with extensive FDA/EU-GMP certifications, anti-tumor and anti-infective API portfolios, and global exports. Highly comparable in product breadth (APIs + intermediates) and regulatory positioning.
- Divis Laboratories: Indian-headquartered API manufacturer with strong peptide and small-molecule capabilities, FDA-inspected facilities, and global export footprint. Closely comparable in peptide/small-molecule API production and regulatory certifications.
- Asymchem Laboratories: Chinese CDMO with strong peptide and small-molecule API capabilities, including GLP-1 peptide synthesis. Closely comparable in peptide API scale-up and FDA-inspected manufacturing footprint.
- Apeloa Pharmaceutical: China-based API and intermediate manufacturer with comparable scale, multi-therapeutic area exposure (anti-infectives, oncology, diabetes), and CDMO capabilities. Operates from a similar Chinese manufacturing base with global export focus, making it a close functional peer.
- Porton Pharma: China-based CDMO specializing in API process development and custom manufacturing, with global regulatory filings. Comparable as a contract manufacturer serving similar pharmaceutical customers.
- Shanghai Desano Pharmaceuticals: China-headquartered manufacturer of APIs and intermediates, including anti-malarial and anti-infective categories, with global export reach. Comparable in mid-tier Chinese API positioning and international market focus.
Regional players
- Shandong Xinhua Pharmaceutical: China-based API and pharmaceutical manufacturer with FDA/EU GMP approvals and broad portfolio including anti-infective and cardiovascular APIs. Comparable in Chinese regulatory positioning and API catalog breadth.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Senova Technology Co. social profiles
Digital presenceSenova Technology Co. compliance and trust
Trust signalCompliance4 records
Senova Technology Co. financial estimates
Financial estimateRevenue estimate
Valuation estimate
Senova Technology Co. leadership team
Management profileNumber of profiles
Senova Technology Co. funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Senova Technology Co. M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Senova Technology Co.
What does Senova Technology Co. do?
Senova Technology Co., Ltd. manufactures and sells Active Pharmaceutical Ingredients (APIs), peptides, advanced intermediates, and fine chemicals from FDA- and EU-GMP-approved facilities. The company supplies anti-viral, anti-bacterial, anti-cancer, anti-coagulant, and anti-diabetes APIs (including SGLT2 inhibitors and Tirzepatide peptide) to global pharmaceutical manufacturers, and offers CMO/CDMO services along with DMF/CMC/SMF regulatory documentation, pre-audit, and translation support.
Is Senova Technology Co. a public or private company?
Senova Technology Co. is a private company. It is classified as unknown and is currently operating.
When was Senova Technology Co. founded?
Senova Technology Co. was founded in 2013. It employs 11 to 50 people.
Where is Senova Technology Co. based?
Senova Technology Co. is headquartered in Shenzhen, China, in the Asia region.
How does Senova Technology Co. make money?
Five revenue lines are on record. API Sales are the primary driver. The others are peptide Sales, advanced Intermediates Sales, CDMO/CMO Services and regulatory Services.
Who are Senova Technology Co.'s main competitors?
Broad incumbents on record are WuXi AppTec, Dr. Reddy's Laboratories and Aurobindo Pharma. Direct peers are Zhejiang Hisun Pharmaceutical, Divis Laboratories, Asymchem Laboratories, Apeloa Pharmaceutical, Porton Pharma and Shanghai Desano Pharmaceuticals. Shandong Xinhua Pharmaceutical is listed as a regional player.
Does Senova Technology Co. have an API?
No public API is recorded for Senova Technology Co..
What industry is Senova Technology Co. in?
Senova Technology Co.'s product category is Active Pharmaceutical Ingredients (APIs). Its primary akta.pro industry code is HLAGAHAM, Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC), with a secondary code of HLAGAKAA, Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA). Its NAICS code is 3254 and its SIC code is 2834.